Company record · CLDX

Celldex Therapeutics, Inc.

Celldex Therapeutics, Inc. disclosed a change in its chief financial officer, effective March 31, 2027. Until then the filing lists Sam Martin in the role. See the filing record.

This record covers what the tracked filings state; it is not a complete history of the company's finance leadership. Spot an error? Send a correction.